tirzepatide

head to head against clash football helmets fight combat
Biotech

BrightGene tops Novo drug in diabetes ahead of Zepbound showdown

BrightGene beat semaglutide on a blood sugar endpoint, giving momentum as it barrels toward a readout from a head-to-head trial against tirzepatide.
Nick Paul Taylor Jun 23, 2025 2:30pm
pipelines in the sun

Lilly's next focus: Testing incretins in neuro, immunology fields

Feb 6, 2025 2:35pm
Close up of horse legs and hooves running on sand track

Biolexis enters small molecule into oral GLP-1 horse race

Sep 13, 2024 12:24pm
pond lilly pads

Arrowhead dips toes into obesity pond with 2 preclinical assets

Aug 14, 2024 3:50pm
baseball field pitch inning

The most valuable R&D projects? You guessed it: obesity

Jul 11, 2024 5:00am
frozen cold viking long boat winter snow

Viking's MASH drug scores where Madrigal's didn't

Jun 4, 2024 1:51pm